These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10457535)

  • 1. Changes in auditory selective attention and event-related potentials following oral administration of D-amphetamine in humans.
    McKetin R; Ward PB; Catts SV; Mattick RP; Bell JR
    Neuropsychopharmacology; 1999 Sep; 21(3):380-90. PubMed ID: 10457535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of decreased catecholamine transmission on ERP indices of selective attention.
    Shelley AM; Catts SV; Ward PB; Andrews S; Mitchell P; Michie P; McConaghy N
    Neuropsychopharmacology; 1997 Mar; 16(3):202-10. PubMed ID: 9138436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain potential indices of novelty processing are associated with preference for amphetamine.
    Gabbay FH; Duncan CC; McDonald CG
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):470-88. PubMed ID: 21186922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Event-related potential indices of auditory selective attention in dependent amphetamine users.
    McKetin R; Solowij N
    Biol Psychiatry; 1999 Jun; 45(11):1488-97. PubMed ID: 10356632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions.
    Chudasama Y; Nathwani F; Robbins TW
    Behav Brain Res; 2005 Mar; 158(1):97-107. PubMed ID: 15680198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons.
    Schreiber H; Stolz-Born G; Pietrowsky R; Kornhuber HH; Fehm HL; Born J
    Biol Psychiatry; 1995 May; 37(10):702-12. PubMed ID: 7640325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans.
    Silber B; Croft R; Camfield DA; Downey LA; Papafotiou K; Stough C
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):492-500. PubMed ID: 22209365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.
    Sevak RJ; Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2010 Jul; 36(4):220-7. PubMed ID: 20560842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orienting and maintenance of spatial attention in audition and vision: an event-related brain potential study.
    Salmi J; Rinne T; Degerman A; Alho K
    Eur J Neurosci; 2007 Jun; 25(12):3725-33. PubMed ID: 17610592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine disrupts P50 suppression in normal subjects.
    Light GA; Malaspina D; Geyer MA; Luber BM; Coleman EA; Sackeim HA; Braff DL
    Biol Psychiatry; 1999 Oct; 46(7):990-6. PubMed ID: 10509182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse.
    Jasinski DR; Krishnan S
    J Psychopharmacol; 2009 Jun; 23(4):419-27. PubMed ID: 19329547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance.
    Strakowski SM; Sax KW; Rosenberg HL; DelBello MP; Adler CM
    Neuropsychopharmacology; 2001 Oct; 25(4):548-54. PubMed ID: 11557168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
    Stoops WW; Vansickel AR; Lile JA; Rush CR
    Pharmacol Biochem Behav; 2007 May; 87(1):20-9. PubMed ID: 17490738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of selective attention as reflected by event-related brain potentials.
    Berman S; Friedman D
    J Exp Child Psychol; 1995 Feb; 59(1):1-31. PubMed ID: 7876768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of inhibition of unattended stimuli in schizophrenic patients: event-related potential correlates during selective attention.
    Iwanami A; Kanamori R; Isono H; Okajima Y; Kamijima K
    Neuropsychobiology; 1996; 34(2):57-62. PubMed ID: 8904732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an acute d-amphetamine administration on context information memory in healthy volunteers: evidence from a source memory task.
    Zeeuws I; Deroost N; Soetens E
    Hum Psychopharmacol; 2010; 25(4):326-34. PubMed ID: 20521323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.
    Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH
    Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.